Both in Pharmaceuticals
Zymeworks vs Biohaven
Over the past year ZYME returned +51.2% and BHVN returned +2.5%; their daily moves had a correlation of 0.19.
ZYME +51.2% BHVN +2.5%Growth of $1, one year, split-adjusted
| Metric | ZYME | BHVN |
|---|---|---|
| Price | $28.57 | $15.22 |
| Market cap | $2.05B | $2.30B |
| Today | −0.14% | −1.30% |
| 1 month | +13.6% | +18.3% |
| 6 months | +6.7% | +50.1% |
| Year to date | +8.5% | +34.8% |
| 1 year | +49.4% | −12.5% |
| Revenue growth (YoY) | −90.6% | — |
| Gross margin | 100.0% | — |
| Net margin | −980.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 55.3× | — |
| Net cash | $270.7M | -$103.2M |
| Dividend yield | — | — |
| Volatility (60d) | 46.5% | 90.8% |
| Short % of float | 13.0% | 14.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).